Nanomolar NG-nitroarginine inhibits NMDA-induced cyclic GMP formation in rat cerebellum
- 1 August 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 184 (2-3), 311-313
- https://doi.org/10.1016/0014-2999(90)90623-e
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitroBritish Journal of Pharmacology, 1990
- Nω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formationEuropean Journal of Pharmacology, 1990
- NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slicesEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Biosynthesis of nitric oxide from l-arginineBiochemical Pharmacology, 1989
- Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brainNature, 1988
- Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclaseEuropean Journal of Pharmacology, 1987
- Cellular Origins of Cyclic GMP Responses to Excitatory Amino Acid Receptor Agonists in Rat Cerebellum In VitroJournal of Neurochemistry, 1987
- Amino acid neurotoxicity: Relationship to neuronal depolarization in rat cerebellar slicesNeuroscience, 1986